Loading, please wait...
The Premier October 20, 2026 CE webinar will be held from 12 - 1 pm EDT. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
340B Drug Discout Program - More Upheaval in 2026, and More to Come in 2027
Speaker: Jason B. Reddish, Principal, Powers, Pyles, Sutter & Verville, PC, Washington, DC
ACPE Universal Activity Number: 0122-0000-26-041-LXX-P [0.1 CEU] [1 Contact Hr.]
Important: When registering for a CE activity, please select the program that aligns with your profession (Pharmacist or Pharmacy Technician). Choosing the correct program is essential to ensure your CE credit is processed accurately and prevents delays in reporting to CPE Monitor.
Date: Oct 20, 2026 12:00 PM - 01:00 PM
Fee
CE Hours
CE Units
Registration closes on Oct 20, 2026 12:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Support/Credits
Tue, Oct 20, 2026
Objectives
- Recognize how the implementation of a 340B “rebate” program will affect cash flow and reporting
- Describe areas of interest for drug manufacturers conducting audits and oversight of 340B pharmacies and entities
- Classify types of drug manufacturer restrictions and reporting into actionable categories
Speaker(s)/Author(s)
|
Jason B. Reddish
|